Skip to main content
Log in

Perfusion volume correlates, percentage of involution, and clinical efficacy at diverse follow-up survey times after MR-guided focused ultrasound surgery in uterine fibroids: first report in a Mexican mestizo population

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the clinical efficacy of magnetic resonance-guided focused ultrasound surgery in a Mexican mestizo population.

Methods

This retrospective study included 159 women (mean age 37 ± 6.4 years, range 22–53 years) from 2008 to 2010. Two hundred sixty-eight symptomatic uterine fibroids were treated using MR-guided focused ultrasound surgery. Parameters included initial perfused volume, final perfused volume, non-perfused volume (NPV), and treated volume ratio (TVR). Follow-up up to 15 months assessed treatment efficacy and symptomatic relief. Non-parametric statistics and the Kaplan-Meier method were performed.

Results

T2-weighted hypointense fibroids showed a frequency of 93.6 %; isointense and hyperintense fibroids had frequencies of 5.60 and 1.1 %. There was a negative correlation between NPV and age (r = -0.083, p = 0.307) and treatment time (r = -0.253, p = 0.001). Median TVR was 96.0 % in small fibroids and 76.5 % in large fibroids. Involution of 50 % and 80 % was achieved at months 6–7 and month 11, respectively. Relief of symptoms was significant (p < 0.05).

Conclusions

Our data show that higher TVR attained immediately post-treatment of MRgFUS favours higher involution percentages at follow-up; however, careful patient selection and use of pretreatment imaging are important components for predicting success using MR-guided focused ultrasound surgery.

Key Points

Type 1 fibroids were the most common (93.2 %).

Age and treated volume were not correlated (r s = -0.215, p = 0.165).

Small fibroids achieved a higher treated volume than large (96.0 % vs. 76.5 %).

A 50 % involution was achieved at 6-month follow-up for type-1 fibroid.

A decrease of 80 % was reached at 11 months for type-1 fibroids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Khan AT, Shehmar M, Gupta JK (2014) Uterine fibroids: current perspectives. Int J Womens Health 6:95–114

    Article  PubMed Central  PubMed  Google Scholar 

  2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107

    Article  PubMed  Google Scholar 

  3. Hanstede MM, Tempany CM, Stewart EA (2007) Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril 88:e495–e497

    Article  Google Scholar 

  4. Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T (2007) Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol 196:e181–e186

    Article  Google Scholar 

  5. Himabindu Y, Sriharibabu M, Nyapathy V, Mishra A (2014) Early evaluation of magnetic resonance imaging guided focused ultrasound sonication in the treatment of uterine fibroids. Indian J Med Res 139:267–272

    PubMed Central  CAS  PubMed  Google Scholar 

  6. van der Kooij SM, Ankum WM, Hehenkamp WJ (2012) Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol 24:368–375

    Article  PubMed  Google Scholar 

  7. Stewart EA, Gedroyc WM, Tempany CM et al (2003) Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 189:48–54

    Article  PubMed  Google Scholar 

  8. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K (2003) MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 226:897–905

    Article  PubMed  Google Scholar 

  9. Hindley J, Gedroyc WM, Regan L et al (2004) MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183:1713–1719

    Article  PubMed  Google Scholar 

  10. Stewart EA, Rabinovici J, Tempany CM et al (2006) Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85:22–29

    Article  PubMed  Google Scholar 

  11. Fennessy FM, Tempany CM, McDannold NJ et al (2007) Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–results of different treatment protocols. Radiology 243:885–893

    Article  PubMed  Google Scholar 

  12. Leslie TA, Kennedy JE (2007) High intensity focused ultrasound in the treatment of abdominal and gynaecological diseases. Int J Hyperth 23:173–182

    Article  CAS  Google Scholar 

  13. Vazquez-Lamadrid J, Fernandez-de Lara Y, Carrasco-Choque A, Romero-Trejo C, Cosme-Labarthe J, Roldan-Valadez E (2011) Principles and technique of magnetic resonance guided focused ultrasound surgery (MRgFUS) in the treatment of uterine fibroids. Gac Med Mex 147:333–341

    PubMed  Google Scholar 

  14. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99:290–300

    Article  PubMed  Google Scholar 

  15. Machtinger R, Fennessy FM, Stewart EA, Missmer SA, Correia KF, Tempany CM (2013) MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials. J Ther Ultrasound 1:23

    Article  PubMed Central  PubMed  Google Scholar 

  16. Rabinovici J, Inbar Y, Revel A et al (2007) Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol 30:771–777

    Article  CAS  PubMed  Google Scholar 

  17. Pallant J (2011) Correlation. In: Pallant J (ed) SPSS survival manual, 4th edn. Allen & Unwin, Crows Nest, pp 128–142

    Google Scholar 

  18. Pallant J (2011) Non-parametric statistics. In: Pallant J (ed) SPSS survival manual, 4th edn. Allen & Unwin, Crows Nest, pp 213–238

    Google Scholar 

  19. Stel VS, Dekker FW, Tripepi G, Zoccali C, Jager KJ (2011) Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract 119:c83–c88

    Article  PubMed  Google Scholar 

  20. Ingelsson E, Lundholm C, Johansson AL, Altman D (2011) Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 32:745–750

    Article  PubMed  Google Scholar 

  21. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F (2002) Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 186:409–415

    Article  PubMed  Google Scholar 

  22. Byun JY, Kim SE, Choi BG, Ko GY, Jung SE, Choi KH (1999) Diffuse and focal adenomyosis: MR imaging findings. Radiographics 19:S161–170

    Article  PubMed  Google Scholar 

  23. Kim HS, Baik JH, Pham LD, Jacobs MA (2011) MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 18:970–976

    Article  PubMed Central  PubMed  Google Scholar 

  24. Funaki K, Fukunishi H, Sawada K (2009) Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol 34:584–589

    Article  CAS  PubMed  Google Scholar 

  25. Gorny KR, Woodrum DA, Brown DL et al (2011) Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol 22:857–864

    Article  PubMed  Google Scholar 

  26. Yoon SW, Cha SH, Ji YG, Kim HC, Lee MH, Cho JH (2013) Magnetic resonance imaging-guided focused ultrasound surgery for symptomatic uterine fibroids: estimation of treatment efficacy using thermal dose calculations. Eur J Obstet Gynecol Reprod Biol 169:304–308

    Article  PubMed  Google Scholar 

  27. Mindjuk I, Trumm CG, Herzog P, Stahl R, Matzko M (2014) MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. doi:10.1007/s00330-014-3538-6

  28. Machtinger R, Inbar Y, Cohen-Eylon S, Admon D, Alagem-Mizrachi A, Rabinovici J (2012) MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success. Hum Reprod 27:3425–3431

    Article  CAS  PubMed  Google Scholar 

  29. Okada A, Morita Y, Fukunishi H, Takeichi K, Murakami T (2009) Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol 34:579–583

    Article  CAS  PubMed  Google Scholar 

  30. Lenard ZM, McDannold NJ, Fennessy FM et al (2008) Uterine leiomyomas: MR imaging-guided focused ultrasound surgery–imaging predictors of success. Radiology 249:187–194

    Article  PubMed Central  PubMed  Google Scholar 

  31. Yamashita Y, Torashima M, Takahashi M et al (1993) Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology 189:721–725

    Article  CAS  PubMed  Google Scholar 

  32. Smart OC, Hindley JT, Regan L, Gedroyc WG (2006) Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol 108:49–54

    Article  CAS  PubMed  Google Scholar 

  33. Hudson SB, Stewart EA (2008) Magnetic resonance-guided focused ultrasound surgery. Clin Obstet Gynecol 51:159–166

    Article  PubMed  Google Scholar 

  34. Tempany CM (2007) From the RSNA refresher courses: image-guided thermal therapy of uterine fibroids. Radiographics 27:1819–1826

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Ernesto Roldan-Valadez. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.This article was supported in part by Medica Sur Clinic and Foundation.

Ana Luz Carrasco-Choque, MD, was enrolled as clinical fellow of the whole-body MRI program during 2009-2010. Ingrid Vivas-Bonilla, MD, was attending radiologist at the MRI unit from 2001 to 2009. Cecilia Romero-Trejo, MD, was attending radiologist at the MRI unit from 2005 to 2010.

Antonio R. Villa MD, PhD, provided statistical advice for the preparation of this manuscript.

One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Methodology: retrospective.

Conflicts of interest

The authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ernesto Roldan-Valadez.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carrasco-Choque, A.L., Lara, Y.Fd., Vivas-Bonilla, I. et al. Perfusion volume correlates, percentage of involution, and clinical efficacy at diverse follow-up survey times after MR-guided focused ultrasound surgery in uterine fibroids: first report in a Mexican mestizo population. Eur Radiol 25, 2905–2912 (2015). https://doi.org/10.1007/s00330-015-3707-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3707-2

Keywords

Navigation